|Videos|August 2, 2021
Roundtable: Synthetic Control Arms and Regulatory/HTA Requirements
Author(s)Parexel
Advertisement
A roundtable discussing the opportunities that synthetic control arms offer for patients and product developers, and how to overcome potential barriers with the use of this burgeoning clinical trial model.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
